Projects per year
Personal profile
Research expertise
Harry van Loen is a scientific expert at the ITM’s Clinical Trials Unit (CTU) and working since 2005 as a clinical data manager.
He has been involved in clinical data management support for studies in Belgium and in Low and Middle Income Countries (LMICs) on various diseases (COVID-19, HIV, Malaria, Tuberculosis, Ebola, Febrile Illness, Sleeping sickness, Buruli ulcer, Leishmaniasis and other neglected tropical diseases (NTDs). In addition specific study groups or topics have been targeted: children, pregnancy, co-infections e.g. TB-HIV, HIV-Leishmanaisis, syndromic approach, medications, diagnostics, vaccinations, emergency research response).
As a coordinating data manager he has been responsible for following activities, resulting in following outputs:
General Activities:
- Coordination and setup of data management (DM) for clinical trials and observational studies
- Preparation of DM documentation
- Designing systems and tools for data management
- Supervising DM processes (planning, data collection, data entry, data review and querying, data management, database lock, reporting, archiving, data sharing)
- Compliancy to ethical, quality, regulatory and funder requirements
- Training and building capacity on data management
General Outputs:
- Documentation: Standard Operating Procedures (SOPs), Case Report Forms (CRFs), Data Management Plan, Data Validation Plan,
- Good Clinical Practice (GCP) and Food & Drug Administration 21 CFR part 11 compliant validated databases and electronic CRFs
- Standardized data sets
- DM training packs
- Co-authoring publications
Services expertise
As member of the ITM's Data Access Committee Harry is involved in the discussion and approval of external applications for ITM's research data and to support ITM staff on data sharing.
Education/Academic qualification
Environmental Sciences, Attestation of 1 year attendance , University of Antwerp
1995 → 1996
Biology (zoology), Master in Science, University of Antwerp
1980 → 1985
Master
Fingerprint
- 1 Similar Profiles
Projects
- 2 Finished
-
AfriCoVER: Characterising transmission parameters of SARS-CoV-2 in a peri-urban setting in Mozambique using population-based surveillance and a high-throughput sero-assay
Ingelbeen, B., Mariën, J., Janssens, S., van Loen, H., Hoof, C., Ingelbeen, B. & Ingelbeen, B.
The European & Developing Countries Clinical Trials Partnership
1/06/20 → 31/10/23
Project: Research Project
-
NIDIAG : Syndromic approach to neglected infectious diseases (NID) at primary health care level : an international collaboration on integrated diagnosis-treatment platforms
Boelaert, M., Büscher, P., Jacobs, J., Ravinetto, R., Polman, K., Bottieau, E., Verdonck, T., Barbé, B., van Griensven, J., Hendrickx, D., van Loen, H., Buyze, J., Meheus, F., Paessens, E. & Everaert, R.
1/11/10 → 30/04/16
Project: Research Project
Research output
- 16 A1: Web of Science-article
-
Feasibility and accuracy of mobile QT interval monitoring strategies in bedaquiline-enhanced prophylactic leprosy treatment
Bergeman, AT., Nourdine, S., Piubello, A., Salim, Z., Braet, SM., Baco, A., Grillone, SH., Snijders, R., Hoof, C., Tsoumanis, A., van Loen, H., Assoumani, Y., Mzembaba, A., Ortuño-Gutiérrez, N., Hasker, E., van der Werf, C. & de Jong, BC., 2024, In: CTS-Clinical and Translational Science. 17, 8, 7 p., e13861.Research output: Contribution to journal › A1: Web of Science-article › peer-review
Open Access -
Pre-exposure intradermal rabies vaccination: a non-inferiority trial in healthy adults on shortening the vaccination schedule from 28 to 7 days
Soentjens, P., Andries, P., Aerssens, A., Tsoumanis, A., Ravinetto, R., Heuninckx, W., van Loen, H., Brochier, B., Van Gucht, S., Van Damme, P., Van Herrewege, Y. & Bottieau, E., 2019, In: Clinical Infectious Diseases. 68, 4, p. 607-614 8 p.Research output: Contribution to journal › A1: Web of Science-article › peer-review
Open AccessFile52 Downloads (Pure) -
Long-term clinical outcomes in visceral leishmaniasis/human immunodeficiency virus-co-infected patients during and after pentamidine secondary prophylaxis in Ethiopia: a single-arm clinical trial
Diro, E., Ritmeijer, K., Boelaert, M., Alves, F., Mohammed, R., Abongomera, C., Ravinetto, R., De Crop, M., Fikre, H., Adera, C., van Loen, H., Tsoumanis, A., Adriaensen, W., Hailu, A. & van Griensven, J., 2018, In: Clinical Infectious Diseases. 66, 3, p. 444-451 8 p.Research output: Contribution to journal › A1: Web of Science-article › peer-review
-
Prednisone for the prevention of paradoxical tuberculosis-associated IRIS
PredART Trial Team, 2018, In: New England Journal of Medicine. 379, 20, p. 1915-1925 11 p.Research output: Contribution to journal › A1: Web of Science-article › peer-review
-
Clinical spectrum, etiology, and outcome of neurological disorders in the rural hospital of Mosango, the Democratic Republic of Congo
Mukendi, D., Lilo Kalo, J-R., Mpanya, A., Minikulu, L., Kayembe, T., Lutumba, P., Barbé, B., Gillet, P., Jacobs, J., Van Loen, H., Yansouni, C. P., Chappuis, F., Ravinetto, R., Verdonck, K., Boelaert, M., Winkler, A. S. & Bottieau, E., 2017, In: American Journal of Tropical Medicine and Hygiene. 97, 5, p. 1454-1460 7 p.Research output: Contribution to journal › A1: Web of Science-article › peer-review
File22 Downloads (Pure)